Page last updated: 2024-09-05

gulonolactone and Infant, Newborn, Diseases

gulonolactone has been researched along with Infant, Newborn, Diseases in 1 studies

*Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, W; Wang, F; Wang, G; Xu, C; Zeng, Z; Zhou, Y1

Other Studies

1 other study(ies) available for gulonolactone and Infant, Newborn, Diseases

ArticleYear
Analysis of serum metabolism in premature infants before and after feeding using GC-MS and the relationship with necrotizing enterocolitis.
    Biomedical chromatography : BMC, 2023, Volume: 37, Issue:1

    Topics: Cross-Sectional Studies; Enterocolitis, Necrotizing; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Maleimides; Premature Birth

2023